Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD7 CAR-T cell therapy

CD7-targeted CAR-T cell therapy · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD7 CAR-T cell therapy, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies [Phase 1]

See pricing